These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23345080)

  • 1. A spontaneous deletion of α-synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: effects on alcohol consumption.
    López-Jiménez A; Walter NA; Giné E; Santos Á; Echeverry-Alzate V; Bühler KM; Olmos P; Giezendanner S; Moratalla R; Montoliu L; Buck KJ; López-Moreno JA
    Synapse; 2013 Jun; 67(6):280-9. PubMed ID: 23345080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB1 receptor neutral antagonist treatment epigenetically increases neuropeptide Y expression and decreases alcohol drinking.
    Dulman RS; Zhang H; Banerjee R; Krishnan HR; Dong B; Hungund BL; Vinod KY; Pandey SC
    Neuropharmacology; 2021 Sep; 195():108623. PubMed ID: 34048869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference.
    Hansson AC; Bermúdez-Silva FJ; Malinen H; Hyytiä P; Sanchez-Vera I; Rimondini R; Rodriguez de Fonseca F; Kunos G; Sommer WH; Heilig M
    Neuropsychopharmacology; 2007 Jan; 32(1):117-26. PubMed ID: 16482090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced motivation to alcohol in transgenic mice expressing human α-synuclein.
    Rotermund C; Reolon GK; Leixner S; Boden C; Bilbao A; Kahle PJ
    J Neurochem; 2017 Nov; 143(3):294-305. PubMed ID: 28833174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of CB1 cannabinoid receptor mRNA in the brain of the chick (Gallus domesticus).
    Stincic TL; Hyson RL
    Brain Res; 2008 Dec; 1245():61-73. PubMed ID: 18835551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of neurotransmitter receptor genes involved in alcohol self-administration in the rat prefrontal cortex, hippocampus and amygdala.
    Pickering C; Avesson L; Lindblom J; Liljequist S; Schiöth HB
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):53-64. PubMed ID: 16876304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.
    McLean JR; Hallett PJ; Cooper O; Stanley M; Isacson O
    Mol Cell Neurosci; 2012 Feb; 49(2):230-9. PubMed ID: 22155155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synuclein expression in the brain and blood during abstinence from chronic alcohol drinking in mice.
    Ziolkowska B; Gieryk A; Wawrzczak-Bargiela A; Krowka T; Kaminska D; Korkosz A; Bienkowski P; Przewlocki R
    Neuropharmacology; 2008 Jun; 54(8):1239-46. PubMed ID: 18456291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desipramine induced changes in the norepinephrine transporter, alpha- and gamma-synuclein in the hippocampus, amygdala and striatum.
    Jeannotte AM; McCarthy JG; Sidhu A
    Neurosci Lett; 2009 Dec; 467(2):86-9. PubMed ID: 19818834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate difference in the endocannabinoid signaling and its modulation by alcohol consumption in alcohol-preferring sP rats.
    Vinod KY; Maccioni P; Garcia-Gutierrez MS; Femenia T; Xie S; Carai MA; Manzanares J; Cooper TB; Hungund BL; Colombo G
    Addict Biol; 2012 Jan; 17(1):62-75. PubMed ID: 21309960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol inhibits spontaneous activity of basolateral amygdala projection neurons in the rat: involvement of the endocannabinoid system.
    Perra S; Pillolla G; Luchicchi A; Pistis M
    Alcohol Clin Exp Res; 2008 Mar; 32(3):443-9. PubMed ID: 18215217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid CB1 receptors are early downregulated followed by a further upregulation in the basal ganglia of mice with deletion of specific park genes.
    García-Arencibia M; García C; Kurz A; Rodríguez-Navarro JA; Gispert-Sáchez S; Mena MA; Auburger G; de Yébenes JG; Fernández-Ruiz J
    J Neural Transm Suppl; 2009; (73):269-75. PubMed ID: 20411785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.
    Cannich A; Wotjak CT; Kamprath K; Hermann H; Lutz B; Marsicano G
    Learn Mem; 2004; 11(5):625-32. PubMed ID: 15466318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking.
    Racz I; Bilkei-Gorzo A; Toth ZE; Michel K; Palkovits M; Zimmer A
    J Neurosci; 2003 Mar; 23(6):2453-8. PubMed ID: 12657705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.
    Kurz A; Double KL; Lastres-Becker I; Tozzi A; Tantucci M; Bockhart V; Bonin M; García-Arencibia M; Nuber S; Schlaudraff F; Liss B; Fernández-Ruiz J; Gerlach M; Wüllner U; Lüddens H; Calabresi P; Auburger G; Gispert S
    PLoS One; 2010 Jul; 5(7):e11464. PubMed ID: 20628651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration.
    Sim-Selley LJ; Schechter NS; Rorrer WK; Dalton GD; Hernandez J; Martin BR; Selley DE
    Mol Pharmacol; 2006 Sep; 70(3):986-96. PubMed ID: 16760363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
    Bedse G; Romano A; Cianci S; Lavecchia AM; Lorenzo P; Elphick MR; Laferla FM; Vendemiale G; Grillo C; Altieri F; Cassano T; Gaetani S
    J Alzheimers Dis; 2014; 40(3):701-12. PubMed ID: 24496074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.